Browsing: Medication & Drugs

Galderma, a global dermatology company, has received filing acceptances for its breakthrough treatment nemolizumab. The drug is designed to treat prurigo nodularis and moderate-to-severe atopic dermatitis in adolescents and adults. It received regulatory nods from authorities in Australia, Singapore, Switzerland, and the United Kingdom via the Access Consortium framework.

Antibiotic misuse is a significant threat. According to the World Health Organization (WHO), antibiotic resistance is one of the top global public health threats, estimated to cause millions of deaths annually.

In the healthcare landscape, the choice between house brand and branded medications often hinges on cost and consumer confidence. Interestingly, scientific evidence counters this by highlighting that the active ingredients in generic (house brand) and brand-name drugs are identical, ensuring comparable efficacy.